MedTrace Logo

Gulf War Digestive Health Study

NCT00680836 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 54

Last updated 2014-08-29

Study results available
· View outcomes & findings →

Summary

The purposes of this study are to estimate the burden of disease due to chronic gastrointestinal illness in PG veterans, to evaluate whether Small Bowel Bacterial Overgrowth (SBBO) is associated with chronic diarrhea in PG veterans, and to determine whether eradication of SBBO reduces symptoms of chronic diarrhea, abdominal pain and bloating in PG veterans.

Conditions

  • Irritable Bowel Syndrome
  • Small Intestinal Bacterial Overgrowth

Interventions

DRUG

Placebo

orally two times per day for 14 days

DRUG

Rifaximin

550 mg orally two times per day for 14 days

Sponsors & Collaborators

Principal Investigators

  • Ashok K Tuteja, MD MPH · Division of Epidemiology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
72 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-10-31
Primary Completion
2008-10-31
Completion
2013-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00680836 on ClinicalTrials.gov